Non-ischemic complications of dermal fillers

Abstract

Dermal fillers have been commonly used for the filling of facial rhytids. As the use of dermal fillers has grown, so has the incidence of non-ischemic complications. These complications range from edema, bruising, and erythema to more complex conditions such as delayed hypersensitivity nodules and biofilms. This article sought to review the causes of various non-ischemic complications, discuss their risk factors, and review management techniques. Certain predisposing factors to delayed hypersensitivity nodules, such as Vycross technology, a history of viral illness, or coronavirus disease 19 (COVID-19) infections, are discussed in detail in this review. Prevention techniques such as patient counseling, elucidating certain patient history (viral illness, dental procedures), the use of aseptic technique, and procedural factors are also discussed. Understanding appropriate management for these complications can also help in treatment. Imaging, such as ultrasound, computed tomography (CT) and magnetic resonance imaging (MRI), has taken on a larger role in the management of non-ischemic complications.

Keywords

Non-ischemic complications / delayed hypersensitivity nodules / COVID-19 hypersensitivity nodules / prevention techniques / granulomas / biofilms / imaging

References

[1] Rzany B,Prager W.Expert guideline on the use of porcine collagen in aesthetic medicine.J Dtsch Dermatol Ges2010;8:210-7

[2] Funt D.Dermal fillers in aesthetics: an overview of adverse events and treatment approaches.Clin Cosmet Investig Dermatol2013;6:295-316 PMCID:PMC3865975

[3] Plastic surgery statistics report 2020. Available from: https://www.plasticsurgery.org/documents/News/Statistics/2020/plastic-surgery-statistics-full-report-2020.pdf. [Last accessed on 14 Aug 2023]

[4] Mehta P,Zhang-nunes S.Ischemic complications of dermal fillers.Plast Aesthet Res2022;9:57

[5] Alam M.Management of complications and sequelae with temporary injectable fillers.Plast Reconstr Surg2007;120:98S-105S

[6] Shah NS,Bugdodel R.The effects of topical vitamin K on bruising after laser treatment.J Am Acad Dermatol2002;47:241-4.

[7] Cohen JL.The role of topical vitamin K oxide gel in the resolution of postprocedural purpura.J Drugs Dermatol2009;8:1020-4.

[8] Kovács RK,Dobozy A.Lack of the effect of topical vitamin K on bruising after mechanical injury.J Am Acad Dermatol2004;50:982-3

[9] Tao JP,Freitag SK.Homeopathic agents or vitamins in reducing ecchymosis after oculofacial surgery: a report by the american academy of ophthalmology.Ophthalmology2022;129:220-6

[10] Goodman GJ,Callan P.Facial aesthetic injections in clinical practice: pretreatment and posttreatment consensus recommendations to minimise adverse outcomes.Australas J Dermatol2020;61:217-25

[11] de Boulle K, Heydenrych I. Patient factors influencing dermal filler complications: prevention, assessment, and treatment.Clin Cosmet Investig Dermatol2015;8:205-14. PMCID:PMC4404720

[12] Chiang YZ,Al-Niaimi F.Dermal fillers: pathophysiology, prevention and treatment of complications.J Eur Acad Dermatol Venereol2017;31:405-13.

[13] Kassir M,Galadari H.Complications of botulinum toxin and fillers: a narrative review.J Cosmet Dermatol2020;19:570-3

[14] Fulton J,Weinkle S.Filler injections with the blunt-tip microcannula.J Drugs Dermatol2012;11:1098-103

[15] Beer KR.Safety and effectiveness of injection of calcium hydroxylapatite via blunt cannula compared to injection by needle for correction of nasolabial folds.J Cosmet Dermatol2014;13:288-96

[16] Urdiales-Gálvez F,Figueiredo V.Treatment of soft tissue filler complications: expert consensus recommendations.Aesthetic Plast Surg2018;42:498-510 PMCID:PMC5840246

[17] Sadeghpour M,Bonati LM,Dover JS.Delayed-onset nodules to differentially crosslinked hyaluronic acids: comparative incidence and risk assessment.Dermatol Surg2019;45:1085-94

[18] Lemperle G,Gauthier-Hazan N.Avoiding and treating dermal filler complications.Plast Reconstr Surg2006;118:92S-107S

[19] Goldberg RA.Filling the periorbital hollows with hyaluronic acid gel: initial experience with 244 injections.Ophthalmic Plast Reconstr Surg2006;22:335-41; discussion 341-3

[20] Kpodzo DS,McCord CD.Malar mounds and festoons: review of current management.Aesthet Surg J2014;34:235-48

[21] Mustak H,Goldberg RA.Filling the periorbital hollows with hyaluronic acid gel: long-term review of outcomes and complications.J Cosmet Dermatol2018;17:611-6

[22] Funt DK.Avoiding malar edema during midface/cheek augmentation with dermal fillers.J Clin Aesthet Dermatol2011;4:32-6 PMCID:PMC3244361

[23] Pessa JE.The malar septum: the anatomic basis of malar mounds and malar edema.Aesthet Surg J1997;17:11-7

[24] Pessa JE,Adrian EK,Garza JR.Anatomy of a “black eye”: a newly described fascial system of the lower eyelid.Clin Anat1998;11:157-61.

[25] Mendelson BC,Adams WP Jr.Surgical anatomy of the midcheek and malar mounds.Plast Reconstr Surg2002;110:885-96; discussion 897-911

[26] Newberry CI,Thomas JR.Updated management of malar edema, mounds, and festoons: a systematic review.Aesthet Surg J2020;40:246-58.

[27] Alghoul M.Retaining ligaments of the face: review of anatomy and clinical applications.Aesthet Surg J2013;33:769-82

[28] Griepentrog GJ,Burkat CN,Rose Jr JG.Periorbital edema following hyaluronic acid gel injection: a retrospective review.Am J Cosmet Surg2011;28:251-4

[29] Zoumalan CI.Managing periocular filler-related syndrome prior to lower blepharoplasty.Aesthetic Plast Surg2019;43:115-22

[30] Iverson SM.Dermal filler-associated malar edema: treatment of a persistent adverse effect.Orbit2017;36:473-5

[31] Gilden DH.Clinical practice. Bell's Palsy.N Engl J Med2004;351:1323-31.

[32] Glass GE.Optimising treatment of Bell's Palsy in primary care: the need for early appropriate referral.Br J Gen Pract2014;64:e807-9 PMCID:PMC4240155

[33] Sullivan FM,Donnan PT.Early treatment with prednisolone or acyclovir in Bell's palsy.N Engl J Med2007;357:1598-607

[34] McAllister DA,Shi T.Global, regional, and national estimates of pneumonia morbidity and mortality in children younger than 5 years between 2000 and 2015: a systematic analysis.Lancet Glob Health2019;7:e47-57 PMCID:PMC6293057

[35] Chen N,He L,Li N.Acupuncture for Bell's palsy..Cochrane Database Syst Rev2010;2010:CD002914 PMCID:PMC7133542

[36] Cardoso JR,Moreira MD,Fontes SV.Effects of exercises on Bell's palsy: systematic review of randomized controlled trials.Otol Neurotol2008;29:557-60

[37] Rootman DB,Goldberg R.Does the tyndall effect describe the blue hue periodically observed in subdermal hyaluronic acid gel placement?.Ophthalmic Plast Reconstr Surg2014;30:524-7

[38] Philipp-Dormston WG,De Boulle K.Global approaches to the prevention and management of delayed-onset adverse reactions with hyaluronic acid-based fillers.Plast Reconstr Surg Glob Open2020;8:e2730 PMCID:PMC7209845

[39] Philipp-Dormston WG,Sommer BM.Consensus statement on prevention and management of adverse effects following rejuvenation procedures with hyaluronic acid-based fillers.J Eur Acad Dermatol Venereol2017;31:1088-95

[40] Fitzgerald R,Sykes JM.Adverse reactions to injectable fillers.Facial Plast Surg2016;32:532-55

[41] Rayess HM,Hanba C.A cross-sectional analysis of adverse events and litigation for injectable fillers.JAMA Facial Plast Surg2018;20:207-14. PMCID:PMC6145786

[42] Sclafani AP.Treatment of injectable soft tissue filler complications.Dermatol Surg2009;35 Suppl 2:1672-80

[43] DeLorenzi C.Complications of injectable fillers, part I.Aesthet Surg J2013;33:561-75

[44] Rzany B,Bachmann F,Wollina U.Hyaluronidase in the correction of hyaluronic acid-based fillers: a review and a recommendation for use.J Cosmet Dermatol2009;8:317-23

[45] Schnabel D,Gaines J.RGM Outbreak Investigation TeamMultistate US outbreak of rapidly growing mycobacterial infections associated with medical tourism to the Dominican Republic, 2013-2014(1).Emerg Infect Dis2016;22:1340-7 PMCID:PMC4982176

[46] Kim JSTW,De Barros Nunes GJ,Munia MA.Herpes zoster as a differential diagnosis for ischemia after facial hyaluronic acid filler.J Clin Aesthet Dermatol2020;13:29-31 PMCID:PMC7819593

[47] Wang C,Yu N.Herpes reactivation after the injection of hyaluronic acid dermal filler: a case report and review of literature.Medicine2020;99:e20394. PMCID:PMC7302668

[48] Cernik C,Brodell RT.The treatment of herpes simplex infections: an evidence-based review.Arch Intern Med2008;168:1137-44

[49] Kim B.Herpes reactivation after injection of dermal fillers.ANZ J Surg2013;83:998

[50] Beleznay K,Carruthers A,Humphrey S.Delayed-onset nodules secondary to a smooth cohesive 20 mg/mL hyaluronic acid filler: cause and management.Dermatol Surg2015;41:929-39

[51] Convery C,Murray G.Delayed-onset nodules (DONs) and considering their treatment following use of hyaluronic acid (HA) fillers.J Clin Aesthet Dermatol2021;14:E59-E67. PMCID:PMC8570356

[52] Arron ST.Persistent delayed-type hypersensitivity reaction to injectable non-animal-stabilized hyaluronic acid.J Cosmet Dermatol2007;6:167-71.

[53] Alijotas-Reig J.Delayed immune-mediated adverse effects related to hyaluronic acid and acrylic hydrogel dermal fillers: clinical findings, long-term follow-up and review of the literature.J Eur Acad Dermatol Venereol2008;22:150-61

[54] Alijotas-Reig J,Puig L.Late-onset inflammatory adverse reactions related to soft tissue filler injections.Clin Rev Allergy Immunol2013;45:97-108

[55] Munavalli GG,Knutsen-Larson S,Matthew E.“COVID-19/SARS-CoV-2 virus spike protein-related delayed inflammatory reaction to hyaluronic acid dermal fillers: a challenging clinical conundrum in diagnosis and treatment”.Arch Dermatol Res2022;314:1-15 PMCID:PMC7871141

[56] Decates T,Velthuis P.Immediate nor delayed type hypersensitivity plays a role in late inflammatory reactions after hyaluronic acid filler injections.Clin Cosmet Investig Dermatol2021;14:581-9 PMCID:PMC8178514

[57] Turkmani MG,Philipp-Dormston WG.Delayed hypersensitivity reaction to hyaluronic acid dermal filler following influenza-like illness.Clin Cosmet Investig Dermatol2019;12:277-83 PMCID:PMC6501047

[58] Rzany B.Understanding, avoiding, and managing severe filler complications.Plast Reconstr Surg2015;136:196S-203S

[59] Duranti F,Bovani B,Rosati ML.Injectable hyaluronic acid gel for soft tissue augmentation. a clinical and histological study.Dermatol Surg1998;24:1317-25

[60] Matarasso SL.Understanding and using hyaluronic acid.Aesthet Surg J2004;24:361-4

[61] Ledon JA,Yang S,Camacho I.Inflammatory nodules following soft tissue filler use: a review of causative agents, pathology and treatment options.Am J Clin Dermatol2013;14:401-11

[62] Modarressi A,Lombardi T.Granulomas and nongranulomatous nodules after filler injection: different complications require different treatments.J Plast Reconstr Aesthet Surg2020;73:2010-5

[63] Lemperle G,Wolters M,Zimmermann U.Foreign body granulomas after all injectable dermal fillers: part 1. Possible causes.Plast Reconstr Surg2009;123:1842-63

[64] Rohrich RJ,Nguyen AT,Fagien S.Soft-tissue filler complications: the important role of biofilms.Plast Reconstr Surg2010;125:1250-6.

[65] Gottfried L.No proof that biofilm bacteria are causing dermal filler granulomas.2019;4:17-22

[66] Alcântara CEP,Cunha JF,Mesquita RA.Granulomatous reaction to hyaluronic acid filler material in oral and perioral region: A case report and review of literature.J Cosmet Dermatol2018;17:578-83

[67] Lemperle G.Foreign body granulomas after all injectable dermal fillers: part 2. Treatment options.Plast Reconstr Surg2009;123:1864-73.

[68] Wolfram D,Piza-Katzer H.Surgery for foreign body reactions due to injectable fillers.Dermatology2006;213:300-4

[69] Jang JW.Evaluation and management of facial granuloma caused by various injection materials.Arch Craniofac Surg2021;22:26-32 PMCID:PMC7968981

[70] Broly M,Picard C.Management of granulomatous foreign body reaction to fillers with methotrexate.J Eur Acad Dermatol Venereol2020;34:817-20.

[71] Friedman PM,Kauvar AN.Safety data of injectable nonanimal stabilized hyaluronic acid gel for soft tissue augmentation.Dermatol Surg2002;28:491-4

[72] Artzi O,Verner I.Resistant and recurrent late reaction to hyaluronic acid-based gel.Dermatol Surg2016;42:31-7

[73] Owczarczyk-Saczonek A,Wygonowska E.The immunogenicity of hyaluronic fillers and its consequences.Clin Cosmet Investig Dermatol2021;14:921-34 PMCID:PMC8291382

[74] Baeva LF,Rios M,Lightfoote MM.Different molecular weight hyaluronic acid effects on human macrophage interleukin 1β production.J Biomed Mater Res A2014;102:305-14

[75] Bhojani-Lynch T.Late-onset inflammatory response to hyaluronic acid dermal fillers.Plast Reconstr Surg Glob Open2017;5:e1532 PMCID:PMC5889432

[76] Lee JM.Foreign body granulomas after the use of dermal fillers: pathophysiology, clinical appearance, histologic features, and treatment.Arch Plast Surg2015;42:232-9 PMCID:PMC4366708

[77] Munavalli GG,Lupo MP.Oral angiotensin-converting enzyme inhibitors for treatment of delayed inflammatory reaction to dermal hyaluronic acid fillers following COVID-19 vaccination-a model for inhibition of angiotensin II-induced cutaneous inflammation.JAAD Case Rep2021;10:63-8. PMCID:PMC7923909

[78] Michon A.ACE inhibitors-an effective treatment for hyaluronic acid soft tissue filler delayed inflammatory reaction following COVID-19 vaccination.J Cosmet Dermatol2022;21:1369-70

[79] Rauso R,Zerbinati N,Fragola R.Adverse events following COVID-19 vaccine in patients previously injected with facial filler: scoping review and case report.Appl Sci2021;11:10888.

[80] Dayan SH,Brindise R.Soft tissue fillers and biofilms.Facial Plast Surg2011;27:23-8

[81] Donlan RM.Biofilms: survival mechanisms of clinically relevant microorganisms.Clin Microbiol Rev2002;15:167-93 PMCID:PMC118068

[82] Monheit GD.The nature of long-term fillers and the risk of complications.Dermatol Surg2009;35 Suppl 2:1598-604

[83] Alhede M,Eickhardt S.Bacterial biofilm formation and treatment in soft tissue fillers.Pathog Dis2014;70:339-46

[84] Christensen LH.Host tissue interaction, fate, and risks of degradable and nondegradable gel fillers.Dermatol Surg2009;35 Suppl 2:1612-9

[85] Christensen L,Bjarnsholt T.Bacterial infection as a likely cause of adverse reactions to polyacrylamide hydrogel fillers in cosmetic surgery.Clin Infect Dis2013;56:1438-44

[86] Marusza W,Sierdzinski J.Treatment of late bacterial infections resulting from soft-tissue filler injections.Infect Drug Resist2019;12:469-80. PMCID:PMC6390860

[87] Høiby N,Moser C.ESCMID Study Group for Biofilms and Consulting External Expert Werner ZimmerliESCMID guideline for the diagnosis and treatment of biofilm infections 2014.Clin Microbiol Infect2015;21 Suppl 1:S1-25

[88] von Csiky-Sessoms SC, Gidumal SS, Marmur E, Lin G. Surgical management of a dermal filler-associated aseptic abscess.Dermatol Surg2021;47:753-4

[89] Nygart JF,Borggren M.Effect of prophylactic antibiotics on polyacrylamide gel safety in facial augmentation.J Drugs Dermatol2014;13:571-3

[90] Ozturk CN,Tung R,Piliang MP.Complications following injection of soft-tissue fillers.Aesthet Surg J2013;33:862-77

[91] Vartanian AJ,Rubin MG.Injected hyaluronidase reduces restylane-mediated cutaneous augmentation.Arch Facial Plast Surg2005;7:231-7.

[92] Zhang-Nunes S,Cahill K.Prospective in vivo evaluation of three different hyaluronic acid gels to varying doses of hyaluronidase with long-term follow-up.J Plast Reconstr Aesthet Surg2021;74:874-80.

[93] Ryu C,Zhang-Nunes S.Response of twelve different hyaluronic acid gels to varying doses of recombinant human hyaluronidase.J Plast Reconstr Aesthet Surg2021;74:881-9

[94] Reddy KK,Anolik R.Calcium hydroxylapatite nodule resolution after fractional carbon dioxide laser therapy.Arch Dermatol2012;148:634-6.

[95] Vrcek IM,Gilliland GD.A novel solution for superficially placed calcium hydroxylapatite (Radiesse) in the inferior eyelid.Orbit2012;31:431-2.

[96] Jung H.Hyaluronidase: an overview of its properties, applications, and side effects.Arch Plast Surg2020;47:297-300 PMCID:PMC7398804

[97] Kim MS,Na CH.Allergic reaction to hyaluronidase use after hyaluronic acid filler injection.J Cosmet Laser Ther2015;17:283-5

[98] Mehta P,Park K,Zhang-Nunes S.Response of five different hyaluronic acid gels to varying doses of recombinant human hyaluronidase.J Plast Reconstr Aesthet Surg2023;76:298-300

[99] De Boulle K,Kono T.A review of the metabolism of 1,4-butanediol diglycidyl ether-crosslinked hyaluronic acid dermal fillers.Dermatologic Surg2013;39:1758-66. PMCID:PMC4264939

[100] Gold MH.Use of hyaluronic acid fillers for the treatment of the aging face.Clin Interv Aging2007;2:369-76 PMCID:PMC2685277

[101] Ugradar S.Quantifying the digestion of cross-linked hyaluronic acid fillers with hyaluronidase.Dermatol Surg2021;47:1233-6

[102] Heydenrych I,De Boulle K.A 10-point plan for avoiding hyaluronic acid dermal filler-related complications during facial aesthetic procedures and algorithms for management.Clin Cosmet Investig Dermatol2018;11:603-11. PMCID:PMC6257077

[103] Bailey SH,Kenkel JM.Etiology, prevention, and treatment of dermal filler complications.Aesthet Surg J2011;31:110-21

[104] Malik E,Harris F.pH dependent antimicrobial peptides and proteins, their mechanisms of action and potential as therapeutic agents.Pharmaceuticals2016;9:67 PMCID:PMC5198042

[105] Lafaille P.Fillers: contraindications, side effects and precautions.J Cutan Aesthet Surg2010;3:16-9 PMCID:PMC2890129

[106] Narins RS,Glogau RG.Recommendations and treatment options for nodules and other filler complications.Dermatol Surg2009;35 Suppl 2:1667-71

[107] Zein M,Pirakitikulr N.Complications after cosmetic periocular filler: prevention and management.Plast Aesthet Res2020;7:44. PMCID:PMC7583139

[108] Gladstone HB.Adverse effects when injecting facial fillers.Semin Cutan Med Surg2007;26:34-9

[109] Glogau RG.Effect of injection techniques on the rate of local adverse events in patients implanted with nonanimal hyaluronic acid gel dermal fillers.Dermatol Surg2008;34 Suppl 1:S105-9

[110] Urdiales-Gálvez F,Bové I.Ultrasound patterns of different dermal filler materials used in aesthetics.J Cosmet Dermatol2021;20:1541-8 PMCID:PMC8252486

[111] Arlette J,Schelke LW.Ultrasound for soft tissue filler facial rejuvenation.J Cutan Med Surg2021;25:456-7

[112] Mlosek RK,Skrzypek DM.High-frequency ultrasound-based differentiation between nodular dermal filler deposits and foreign body granulomas.Skin Res Technol2018;24:417-22

[113] Park KE,Tran C,Zhou Q.A comparison of five point-of-care ultrasound devices for use in ophthalmology and facial aesthetics.Ultrasound2023;online ahead of print

[114] Ginat DT.Imaging of facial fillers: additional insights.AJNR Am J Neuroradiol2012;33:E140-1 PMCID:PMC7965586

[115] Mundada P,Boudabbous S,Platon A.Injectable facial fillers: imaging features, complications, and diagnostic pitfalls at MRI and PET CT.Insights Imaging2017;8:557-72 PMCID:PMC5707222

[116] Tal S,Bryan T.MRI in detecting facial cosmetic injectable fillers.Head Face Med2016;12:27 PMCID:PMC5011976

[117] Master M.Hyaluronic acid filler longevity and localization: magnetic resonance imaging evidence.Plast Reconstr Surg2021;147:50e-3e

[118] Kadouch JA,Kadouch DJ,Karim RB.Complications after facial injections with permanent fillers: important limitations and considerations of MRI evaluation.Aesthet Surg J2014;34:913-23.

[119] Di Girolamo M, Mattei M, Signore A, Grippaudo FR. MRI in the evaluation of facial dermal fillers in normal and complicated cases.Eur Radiol2015;25:1431-42.

[120] Master M.Long-term MRI follow-up of hyaluronic acid dermal filler.Plast Reconstr Surg Glob Open2022;10:e4252 PMCID:PMC9007185

[121] Savva D,Amenta F.Hypersensitivity reaction to hyaluronic acid dermal filler after the Pfizer vaccination against SARS-CoV-2.Int J Infect Dis2021;113:233-5 PMCID:PMC8479353

[122] Michon A.Hyaluronic acid soft tissue filler delayed inflammatory reaction following COVID-19 vaccination-a case report.J Cosmet Dermatol2021;20:2684-90 PMCID:PMC8447415

[123] Rowland-Warmann MJ.Hypersensitivity reaction to hyaluronic acid dermal filler following novel coronavirus infection-a case report.J Cosmet Dermatol2021;20:1557-62 PMCID:PMC8251125

[124] Shome D,Vadera S.Delayed hypersensitivity reaction to hyaluronic acid dermal filler post-COVID-19 viral infection.J Cosmet Dermatol2021;20:1549-50 PMCID:PMC8251037

[125] Kalantari Y,Aryanian Z,Goodarzi A.First reported case of delayed-type hypersensitivity reaction to non-hyaluronic acid Polycaprolactone dermal filler following COVID-19 vaccination: a case report and a review of the literature.Clin Case Rep2022;10:e05343 PMCID:PMC8818279

[126] Ortigosa LCM,Suárez MV,Prestes-Carneiro LE.Hypersensitivity reaction to hyaluronic acid dermal filler after COVID-19 vaccination: a series of cases in São Paulo, Brazil.Int J Infect Dis2022;116:268-70. PMCID:PMC8767935